Navneet Majhail was named deputy physician-in-chief of blood cancers for the Sarah Cannon Transplant and Cellular Therapy Network (formerly the Sarah Cannon Blood Cancer Network).Â
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with the New Brunswick Development Corporation, broke ground on the state’s first freestanding cancer hospital.Â
University of California, San Francisco has established a initiative to propel the development of living therapeutics and bring them quickly to patients.
COTA, an oncology real-world data and analytics company, and University of Chicago Medicine have established a research collaboration agreement to investigate racial disparities of care in multiple myeloma to better understand differences in the diagnosis, treatment patterns, and outcomes of patients with this type of cancer.
A group of cancer centers is collaborating with Genentech on a clinical trial diversity, launching the Advancing Inclusive Research Site Alliance.Â
In a joint position statement, the American Society of Clinical Oncology and Friends of Cancer Research said individuals with cancer or a history of cancer should be eligible for clinical trials—including COVID-19 vaccine trials—unless there is safety justification for exclusion.
Suresh S. Ramalingam was named executive director of Winship Cancer Institute of Emory University.
John V. Cox, a medical oncologist and professor at the University of Texas Southwestern, has received ASCO’s Joseph V. Simone Award and Lecture for Excellence in Quality and Safety in the Care of Patients With Cancer.Â
Conquer Cancer, the ASCO Foundation, has named Josephine Lopes Cardozo, Abdul Rafeh Naqash, Antonio Di Meglio, Amy Yuan Wang, and Alanna Church as Special Merit Award recipients of the 2021 ASCO annual meeting.
Conquer Cancer, the ASCO Foundation, has named the recipients of its 2021 Medical Student Rotation for Underrepresented Populations and Annual Meeting Research Award.Â
